Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with glioblastoma (a type of brain tumour), confirmed by tissue testing, where the cancer has come back either based on imaging scans or further tissue testing
- People aged 18 or older
- People who are at least 12 weeks past completing radiation therapy after brain surgery
- People whose general physical functioning meets a minimum level on a standard medical scale called the Karnofsky Performance Status (KPS), scoring 60 or above (confirm with trial site)
- People whose doctors expect them to survive for more than 3 months
- People whose blood, liver, kidney, and other organ function results meet specific minimum levels on lab tests — including healthy enough levels of red blood cells, white blood cells, platelets, liver enzymes, kidney function markers, protein levels, and thyroid hormone levels (confirm with trial site for exact values)
- People who are willing to take part voluntarily and sign a consent form agreeing to follow the study requirements
Who may not be able to join:
- People who need to take steroid medications (such as prednisone) at a dose higher than 10mg per day or the equivalent
- People who have other uncontrolled brain or nervous system conditions not related to their cancer
- People who have had another type of cancer in the past 5 years or currently have one, with the exception of certain fully treated cancers including skin basal cell carcinoma, cervical carcinoma in situ, and thyroid papilloma
- People with serious or uncontrolled heart conditions, such as significant heart failure, unstable chest pain, a heart attack within the past year, or certain heart rhythm problems that have required medical treatment
- People who had a serious infection — such as severe pneumonia or a bloodstream infection requiring hospitalisation — within the past 4 weeks
- People with active autoimmune diseases (conditions where the immune system attacks the body), such as lung inflammation, colitis, hepatitis, or thyroid disorders — though people with vitiligo or childhood asthma or allergies that no longer require treatment may still be considered
- People with a history of immune system deficiency conditions, including HIV, other immune deficiency diseases, or those who have had an organ or bone marrow transplant
- People with active tuberculosis (TB), a TB infection in the past year, or a prior TB infection that was not properly treated
- People with active hepatitis B or hepatitis C infections at levels above specified thresholds on blood tests
- People with a known history of misusing drugs or alcohol
- People the trial investigators judge to be unsuitable for the trial for other medical reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 07562526191
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
progression free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.